Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference


CHATHAM, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will participate virtually in the BIO CEO & Investor Conference, which is being held February 14-17, 2022.

The Company’s pre-recorded presentation will be made available during the conference to registered conference participants through the BIO CEO & Investor Conference website at Beginning February 17th, the presentation will also be available under the IR Events tab of the Investors section of the Tonix website at

Read more: